51 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from … Data. To the Company’s knowledge, no person has commenced any proceedings relating to the Company’s or any Subsidiary’s information privacy or data
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and market, sell and distribute any products for which we obtain marketing approval. In addition, we may be subject to transparency laws and patient privacy … obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
and patient privacy regulation by the federal government and by the U.S. states and foreign jurisdictions in which we conduct our business. The applicable … certain obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually
8-K
EX-1.1
431734fdw2tmjvhvc
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
vgt mtlaeusmi5m2
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
ozn9wxyt rqgksy
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
z78fgcia4mhk z8ax9gx
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
0i8alrv
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
0v801e0 e5y1rth
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
6dtlpg86
23 Jun 20
Prospectus supplement for primary offering
4:06pm